Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microsurfaced vs Control Cadaveric Grafts for Deep Burn Wounds
NCT04589442Phase 4Recruiting
- Sponsor
- CellTherX
- Start
- Jan 2021
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by CellTherX. Primary endpoint: Time to wound bed preparedness at 6 weeks. Started Jan 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04589442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04589442.